Review
Year 2018,
Volume: 10 Issue: 4, 35 - 38, 16.07.2018
Abstract
Abstract
Infants with a diagnosis of bronchopulmonary dysplasia should be followed upclosely for a long time. Planning for discharge from the hospital should be carriedout systematically, with the correct identification of risks and minimizing medicalneeds. Nutrition, vitamin and calory supplementation, immunization and infection control are crucial. Respiratory problems should be scrutinized and oxygen levels should be checked frequently. These infants need frequent hospitalizations as wellas wheezing attacks in the short term while the risk of chronic obstructive lung disease is increased in the long term. Neurodevelopmental delay is not rare. However,mortality rate has been decreased recently.
References
- Kaynaklar 1.Shennan A, Dunn MS; Ohlsson A et al. Abnormal pulmonaryoutcomes in premature infants: prediction from oxygen requi-rements in the neonatal period. Pediatrics 1988; 82: 527-32 2.Coalson JJ. Pathology of new bronchopulmonary dysplasia.Semin Neonatal 2003; 8: 73-81 3.Choi CW, Kim BI, Park JD et al. Risk factors for the differenttypse of chronic lung diseaases of prematurity according tothe preceding respiratory distress syndrome. Pediatr Int 2005;47: 417-23 4.Ovalı F. Bronkopulmoner Displazi. In: Dağoğlu T, Ovalı F.Neonatoloji 3. Baskı. Nobel Tıp Kitapevi, İstanbul 2018; 535-560 5.Allen J, Zwerdling R, Ehrenkranz R et al. Statement on the careof the child with chronic lung disease of infancy and childho-od. Am J Respir Crit Care Med 2003; 168: 356-96 6.Kaczmarczyk K, Wiszomirska I, Szturmowicz M, Magiera A.Are preterm born survivors at risk of long term respiratorydisease? Ther Adv Respir Dis 2017; 11(7): 277-287 7.Türk Neonatoloji Derneği Palivizumab kullanma önerileri.http://www.neonatology.org.tr/neonatoloji/guncel/ 8.Miller NW, Woo P, Kellman RK, Slagle TS. Tracheobronchi-al abnormalities in infants with bronchopulmonary dysplasia.J Pediatr 1987; 111: 779-82 9.Pierro M, Ciarmoli E, Thebaud B. Bronchopulmonary dyspla-sia and chronic lung disease. Clin Perinatol 2015; 42: 889-910 10.Saugstad OD, Aune D. Optimal oxygenation of extremely lowbirth weight infants: A meta-analysis and systematic reviewof oxygen saturation target studies. Neonatology 2014; 105:55-63 11.Groothuis JR, Louch GK; Van Eman C. Outpatient manage-ment of the Preterm infant. J Respir Care Prac 1996; 69-73 12.Singer L, Yamashita T, Lilien L et al. A longitudinal study of de-velopmental outcome of infants with bronchopulmonary dyspla-sia and very low birth weight. Pediatrics 1997; 100: 987-93 13.Northway Jr WH, Moss RB Carlisle KB et al. Late pulmonarysequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323: 1793-9 14.Korhonen P, Laitinen J, Hydodynmaa E et al. Respiratory out-come in school-aged, very low birthweight children in the sur-factant era. Acta Paediatr 2004; 93: 316-21 15.Yüksel B, Greenough A, Karani J et al. Chest radiograph sco-ring system for use in Preterm infants. BR J Radiol 1991; 64:1015-18 16.Cunningham CK, McMillan JA, Gross SJ, Rehospitalizationfor respiratory illness in infants of less than 32 weeks’ gesta-tion. Pediatrics 1991; 88: 527-32 17.Halvorsen T, Skadberg BT, Eide GE et al. characteristics ofasthma andn airway hyper-responsiveness after prematurebirth. Pediatr Allergy Immunol 2005; 16: 487-94 18.Kumar R; Yu Y, Story RE et al. Prematurity, choriamnionitisand the development of recurrent wheezing: a prospective birthcohort study. J Allergy Clin Immunol 2008; 121: 878-84 e6 19.Doyle LW, Anderson PJ. Long-term outcomes of bronchopulmo-nary dysplasia. Semin Fetal Neonatal Med 2009; 14: 391-95 20.Vosdoganes P, Hoodges RJ, Lim R. et al. Human amnion epit-helial cells as a treatment for inflammation induced fetal lunginjury in sheep. Am J Obstet Gynecol 2011; 205: 156: e126-e133 21.Farel AM; Hooper SR; Teplin SW et al. Very low birth we-ight infants at seven years: an assessment of the health andneurodevelopmental risk conveyed by chronic lung disease.J Learn Disabil 1998; 31: 118-26 22.Vrlenich LA, Bozynski MEA, Shyr Y et al. The effect of bronc-hopulmonary dysplasia on growth at school age. Pediatrics1995; 95: 855-9 23.Yetik H, Ovalı F. Effects of intravitreal anti-VEGF (bevaci-zumab) therapy on the development and clinical course ofbronchopulmonary dysplasia. Iranian J Pediatr 2016;26(6):e4637
Year 2018,
Volume: 10 Issue: 4, 35 - 38, 16.07.2018
Abstract
Öz
Bronkopulmoner displazi tanısı konan bebeklerin taburcu olduktan sonra uzun süreli ve yakından takibi gerekir. Öncelikle taburculuk planlamasının sistematik bir şekilde yapılması, risklerin belirlenmesi ve tıbbi ihtiyaçlarının minimuma indirilmesiyerinde olur. Beslenme, vitamin ve kalori desteği, aşılama, enfeksiyonlardan koruma önemlidir. Solunum sistemi sorunlarının yakından takibi, oksijen düzeylerinin dü-zenlenmesi ihmal edilmemelidir. Bu bebeklerde erken dönemde sık hastane yatışları, wheezing, ileride kronik obstrüktif akciğer hastalığı gelişme riski yüksektir. Nörogelişimsel açıdan gerilik sıktır. Mortalite ise eski yıllara kıyasla azalmıştır.
References
- Kaynaklar 1.Shennan A, Dunn MS; Ohlsson A et al. Abnormal pulmonaryoutcomes in premature infants: prediction from oxygen requi-rements in the neonatal period. Pediatrics 1988; 82: 527-32 2.Coalson JJ. Pathology of new bronchopulmonary dysplasia.Semin Neonatal 2003; 8: 73-81 3.Choi CW, Kim BI, Park JD et al. Risk factors for the differenttypse of chronic lung diseaases of prematurity according tothe preceding respiratory distress syndrome. Pediatr Int 2005;47: 417-23 4.Ovalı F. Bronkopulmoner Displazi. In: Dağoğlu T, Ovalı F.Neonatoloji 3. Baskı. Nobel Tıp Kitapevi, İstanbul 2018; 535-560 5.Allen J, Zwerdling R, Ehrenkranz R et al. Statement on the careof the child with chronic lung disease of infancy and childho-od. Am J Respir Crit Care Med 2003; 168: 356-96 6.Kaczmarczyk K, Wiszomirska I, Szturmowicz M, Magiera A.Are preterm born survivors at risk of long term respiratorydisease? Ther Adv Respir Dis 2017; 11(7): 277-287 7.Türk Neonatoloji Derneği Palivizumab kullanma önerileri.http://www.neonatology.org.tr/neonatoloji/guncel/ 8.Miller NW, Woo P, Kellman RK, Slagle TS. Tracheobronchi-al abnormalities in infants with bronchopulmonary dysplasia.J Pediatr 1987; 111: 779-82 9.Pierro M, Ciarmoli E, Thebaud B. Bronchopulmonary dyspla-sia and chronic lung disease. Clin Perinatol 2015; 42: 889-910 10.Saugstad OD, Aune D. Optimal oxygenation of extremely lowbirth weight infants: A meta-analysis and systematic reviewof oxygen saturation target studies. Neonatology 2014; 105:55-63 11.Groothuis JR, Louch GK; Van Eman C. Outpatient manage-ment of the Preterm infant. J Respir Care Prac 1996; 69-73 12.Singer L, Yamashita T, Lilien L et al. A longitudinal study of de-velopmental outcome of infants with bronchopulmonary dyspla-sia and very low birth weight. Pediatrics 1997; 100: 987-93 13.Northway Jr WH, Moss RB Carlisle KB et al. Late pulmonarysequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323: 1793-9 14.Korhonen P, Laitinen J, Hydodynmaa E et al. Respiratory out-come in school-aged, very low birthweight children in the sur-factant era. Acta Paediatr 2004; 93: 316-21 15.Yüksel B, Greenough A, Karani J et al. Chest radiograph sco-ring system for use in Preterm infants. BR J Radiol 1991; 64:1015-18 16.Cunningham CK, McMillan JA, Gross SJ, Rehospitalizationfor respiratory illness in infants of less than 32 weeks’ gesta-tion. Pediatrics 1991; 88: 527-32 17.Halvorsen T, Skadberg BT, Eide GE et al. characteristics ofasthma andn airway hyper-responsiveness after prematurebirth. Pediatr Allergy Immunol 2005; 16: 487-94 18.Kumar R; Yu Y, Story RE et al. Prematurity, choriamnionitisand the development of recurrent wheezing: a prospective birthcohort study. J Allergy Clin Immunol 2008; 121: 878-84 e6 19.Doyle LW, Anderson PJ. Long-term outcomes of bronchopulmo-nary dysplasia. Semin Fetal Neonatal Med 2009; 14: 391-95 20.Vosdoganes P, Hoodges RJ, Lim R. et al. Human amnion epit-helial cells as a treatment for inflammation induced fetal lunginjury in sheep. Am J Obstet Gynecol 2011; 205: 156: e126-e133 21.Farel AM; Hooper SR; Teplin SW et al. Very low birth we-ight infants at seven years: an assessment of the health andneurodevelopmental risk conveyed by chronic lung disease.J Learn Disabil 1998; 31: 118-26 22.Vrlenich LA, Bozynski MEA, Shyr Y et al. The effect of bronc-hopulmonary dysplasia on growth at school age. Pediatrics1995; 95: 855-9 23.Yetik H, Ovalı F. Effects of intravitreal anti-VEGF (bevaci-zumab) therapy on the development and clinical course ofbronchopulmonary dysplasia. Iranian J Pediatr 2016;26(6):e4637
There are 1 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | makale |
| Authors | |
| Publication Date | July 16, 2018 |
| Published in Issue | Year 2018 Volume: 10 Issue: 4 |
